Andrew Retter - Jun 1, 2024 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Chief Medical Officer
Signature: /s/ Andrew Retter
Stock symbol: VNRX
Transactions as of: Jun 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/4/2024, 04:06 PM
Previous filing: May 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Award	$0	+8.33 K	+8.33%	$0.00	108 K	Jun 1, 2024	Direct	F1

Explanation of Responses:

Id	Content
F1	On June 1, 2024, the reporting person was awarded 8,326 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,776 units, 2,775 units, and 2,775 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Content

On June 1, 2024, the reporting person was awarded 8,326 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,776 units, 2,775 units, and 2,775 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.